Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for breast density reduction
IRCT20100706004329N9Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast density comparing Metformin with Placebo (2 arms). Primary endpoint: Breast density. Started Nov 2020; status: completed.
02
Drugs
metformin
03
Conditions
breast density
Beyond the preview
Go deeper on IRCT20100706004329N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100706004329N9.